Zobrazeno 1 - 10
of 257
pro vyhledávání: '"M. Titeler"'
Publikováno v:
Brain research. Molecular brain research. 8(4)
We report here of an abnormal circling behavior expressed in the TgX15 transgenic mouse line as a result of insertional mutagenesis. Homozygous transgenic mice expressed the phenotype while heterozygous transgenics were normal. We also found that the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::444f3ee7ca0aa9171c8a547e76bd7856
https://pubmed.ncbi.nlm.nih.gov/1980140
https://pubmed.ncbi.nlm.nih.gov/1980140
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 252(2)
Although dopamine is known to be present in sympathetic ganglia, its role and mode of action as a peripheral neurotransmitter are still poorly understood. Dopaminergic agonists have been shown to inhibit adrenal catecholamine release and calcium upta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2075acd7ecb8c7c00117258d2466e4fb
https://pubmed.ncbi.nlm.nih.gov/2156054
https://pubmed.ncbi.nlm.nih.gov/2156054
Autor:
Philip Seeman, M. Titeler
Publikováno v:
Experientia. 34:1490-1492
The clinical potency of 3 drugs, apomorphine, N-propylnorapomorphine, and bromocryptine, have been found to be closely correlated to their potencies in competing for 3H-haloperidol and 3H-spiroperidol both of which label the dopamine receptor. This c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f0459423abe4e57dee888c4647065e8
https://doi.org/10.1007/bf01932371
https://doi.org/10.1007/bf01932371
Autor:
Dwulet, Gregory E.
Publikováno v:
RSC Medicinal Chemistry; Jul2024, Vol. 15 Issue 7, p2508-2513, 6p
Publikováno v:
Molecular pharmacology. 24(3)
[3H]Prazosin binding to alpha 1-adrenergic receptors was investigated in homogenates of tissue from the porcine pituitary neurointermediate lobe. Potent alpha 1-adrenergic antagonists such as prazosin, WB-4101, and phentolamine displayed high potency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bf09f9b1049b21602d60dd27af54a01d
https://pubmed.ncbi.nlm.nih.gov/6138705
https://pubmed.ncbi.nlm.nih.gov/6138705
Autor:
M, Titeler, P, Seeman
Publikováno v:
Advances in biochemical psychopharmacology. 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a8ff5dcaaacf4a02257c355d084fdeb6
https://pubmed.ncbi.nlm.nih.gov/6996440
https://pubmed.ncbi.nlm.nih.gov/6996440
Publikováno v:
Communications in psychopharmacology. 3(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5b9ec7954b02997165d67bc950de2d5b
https://pubmed.ncbi.nlm.nih.gov/546589
https://pubmed.ncbi.nlm.nih.gov/546589
Autor:
P. Seeman, M. Titeler
Because it was known that [ 3 H]dihydroergocryptine can label α-adrenergic receptors as well as dopamine receptors, this study was done to establish the conditions under which [ 3 H]dihydroergocryptine would be a reliable ligand for selective labeli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f4d5b9e34b96c71c9180245d7c4be97
https://europepmc.org/articles/PMC392529/
https://europepmc.org/articles/PMC392529/
Publikováno v:
Biochemical pharmacology. 36(19)
The affinities of putative serotonin receptor agonists and antagonists for 5-HT1A, 5-HT1B, 5-HT1C, and 5-HT2 receptors were assayed using radioligand binding assays. The 5-HT1 sites were labeled with the agonist radioligands [3H]-8-hydroxy-2-(di-n-pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f3da887429dc5c3114c4e82a0882cdac
https://pubmed.ncbi.nlm.nih.gov/3663239
https://pubmed.ncbi.nlm.nih.gov/3663239
Publikováno v:
Psychopharmacology bulletin. 22(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0d5434f66bf825d3dd3bfe8e4e0dfe80
https://pubmed.ncbi.nlm.nih.gov/3025916
https://pubmed.ncbi.nlm.nih.gov/3025916